-
-
Active in discovery and development of
Go To Products
novel biotherapeutics
to conquer unmet medical needs and iPSC technologyProduct and Service
-
-
NEXEL is a leading industrial front runner
Go To News
as a Korean iPSC Derived Cell Provider
with discovery and development
of drug, biotherapeutics, and iPSC technologyNEWSMORE
- iPSC Technology
- Korean iPSC Derived Cell Provider
- NEXEL
- ICH S7B CiPA
- Human Cardiomyocytes
- iPSC Derived Cardiomyocytes
- iPSC derived hepatocytes
- iPSC Derived Neurons
- MEA assay
- iPSC Derived Cell
- Cardiomyocyte Contractility
- 3D Tissue Contractility Analysis
- 3D Engineered Organoid Plates
- Cell Engineered Stretcher Plates
- 3D Organoid Plates
- Cell Nanosurface Plates
- Cardiac Safety Service
- hERG Assay
- Cardiotoxicity Test Screening
- Cardiomyocyte Viability
- iPSC Disease Model Service
- iPSC Reprogramming
- Drug Candidate Screening
- Drug Cardiotoxicity Test
- Disease Modeling
-
iPSC Technology
Contact Information
- Address: 8F, 55 Magokdong-ro, Gangseo-gu, Seoul, Republic of Korea(07802)
- Business Registration No.: 109-86-37282
- CEO: Choongseong Han
- Tel: +82-2-2088-8886
- Fax: +82-2-2088-8884
- E-mail: support@nexel.co.kr
-